🚀 VC round data is live in beta, check it out!
Sopharma Properties Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sopharma Properties and similar public comparables like Kinea FII, Hispanotels Inversiones, Serrano 61 Desarrollo, Profuturo and more.
Sopharma Properties Overview
About Sopharma Properties
Sopharma Properties REIT is a special purpose investment company for securitization of real estate.
Founded
2006
HQ
Employees
1
Website
Sectors
Financials (FY)
EV
$118M
Sopharma Properties Financials
Sopharma Properties reported last fiscal year revenue of $9M and EBITDA of $8M.
In the same fiscal year, Sopharma Properties generated $7M in gross profit, $8M in EBITDA, and $8M in net income.
Sopharma Properties P&L
In the most recent fiscal year, Sopharma Properties reported revenue of $9M and EBITDA of $8M.
Sopharma Properties expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $9M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $7M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 78% | XXX | XXX | XXX |
| EBITDA | — | XXX | $8M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 98% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 67% | XXX | XXX | XXX |
| Net Profit | — | XXX | $8M | XXX | XXX | XXX |
| Net Margin | — | XXX | 98% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Sopharma Properties Stock Performance
Sopharma Properties has current market cap of $118M, and enterprise value of $118M.
Market Cap Evolution
Sopharma Properties' stock price is $5.37.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $118M | $118M | 0.0% | XXX | XXX | XXX | $0.39 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSopharma Properties Valuation Multiples
Sopharma Properties trades at 13.7x EV/Revenue multiple, and 13.9x EV/EBITDA.
Sopharma Properties Financial Valuation Multiples
As of April 20, 2026, Sopharma Properties has market cap of $118M and EV of $118M.
Equity research analysts estimate Sopharma Properties' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sopharma Properties has a P/E ratio of 13.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $118M | XXX | $118M | XXX | XXX | XXX |
| EV (current) | $118M | XXX | $118M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 13.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 13.9x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 20.6x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 17.5x | XXX | XXX | XXX |
| P/E | — | XXX | 13.9x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 20.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sopharma Properties Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Sopharma Properties Margins & Growth Rates
Sopharma Properties' revenue in the last fiscal year grew by 6%.
Sopharma Properties' revenue per employee in the last FY averaged $8.6M, while opex per employee averaged $1.0M for the same period.
Sopharma Properties Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 98% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (7%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $8.6M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $1.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 12% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Sopharma Properties Public Comps
See public comps and valuation multiples for other Asset Management comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Sopharma Properties | XXX | XXX | XXX | XXX | XXX | XXX |
| Kinea FII | XXX | XXX | XXX | XXX | XXX | XXX |
| Hispanotels Inversiones | XXX | XXX | XXX | XXX | XXX | XXX |
| Serrano 61 Desarrollo | XXX | XXX | XXX | XXX | XXX | XXX |
| Profuturo | XXX | XXX | XXX | XXX | XXX | XXX |
| Entrecampos Cuatro | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sopharma Properties M&A Activity
Sopharma Properties acquired XXX companies to date.
Last acquisition by Sopharma Properties was on XXXXXXXX, XXXXX. Sopharma Properties acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Sopharma Properties
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSopharma Properties Investment Activity
Sopharma Properties invested in XXX companies to date.
Sopharma Properties made its latest investment on XXXXXXXX, XXXXX. Sopharma Properties invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Sopharma Properties
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sopharma Properties
| When was Sopharma Properties founded? | Sopharma Properties was founded in 2006. |
| Where is Sopharma Properties headquartered? | Sopharma Properties is headquartered in Bulgaria. |
| How many employees does Sopharma Properties have? | As of today, Sopharma Properties has over 1 employees. |
| Is Sopharma Properties publicly listed? | Yes, Sopharma Properties is a public company listed on Bulgarian Stock Exchange. |
| What is the stock symbol of Sopharma Properties? | Sopharma Properties trades under SFI ticker. |
| When did Sopharma Properties go public? | Sopharma Properties went public in 2006. |
| Who are competitors of Sopharma Properties? | Sopharma Properties main competitors are Kinea FII, Hispanotels Inversiones, Serrano 61 Desarrollo, Profuturo. |
| What is the current market cap of Sopharma Properties? | Sopharma Properties' current market cap is $118M. |
| What is the current revenue of Sopharma Properties? | Sopharma Properties' last fiscal year revenue is $9M. |
| What is the current EV/Revenue multiple of Sopharma Properties? | Current revenue multiple of Sopharma Properties is 13.7x. |
| Is Sopharma Properties profitable? | No, Sopharma Properties is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.